Latest News : Challenges in Immuno-oncology (I-O) Market 2018 : Future Use, Trial Design and Combination Strategies

ResearchMoz presents professional and in-depth study of "Challenges in Immuno-oncology (I-O): Future Use, Trial Design and Combination Strategies".

Summary

Immuno-oncology (I-O) is the treatment of cancer with immunotherapy, by using therapies to stimulate or suppress the bodys own immune system to fight cancer.

Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1843600

Several distinct modalities of immunotherapy exist, including cytokines, vaccines, viruses, adoptive cell transfer, and checkpoint blockade using monoclonal antibodies.

This report provides an assessment of the current status and future challenges of immuno-oncology across many indications. Overall, GlobalData expects innovative trial design and new combination drug approvals to drive immuno-oncology market growth.

Scope

This report combines primary research with a cross-specialty I-O KOL panel with in-house analyst expertise to provide an assessment of the marketplace. Components of the slide deck include -
- Primary research with 20 US- and EU-based KOLs, from eight cancer specialties - breast, gastrointestinal, genitourinary, head & neck, lung, melanoma, sarcoma and hematology
- Charts summarizing KOLs opinions and identifying response patterns
- Call-outs of key information and details
- KOL quotes
- Insight from GlobalDatas specialist oncology analysts

View Complete TOC with tables & Figures @ https://www.researchmoz.us/challenges-in-immuno-oncology-i-o-future-use-trial-design-and-combination-strategies-report.html/toc

Reasons to buy

- Develop and design your in-licensing and out-licensing strategies through a review of the potential of novel agents across tumor specialties by mechanism of action.
- Develop business strategies by understanding the trends shaping and driving the global immuno-oncology market.
- Drive revenues by understanding the key trends, innovative strategies and trial designs likely to impact the global immuno-oncology market in the future.
- Organize your sales and marketing efforts by understanding the immunotherapy combination approaches across indications that present maximum opportunities for consolidations, investments, and strategic partnerships.

Table of Contents

1. Introduction
1.1 Related Reports 3
1.2 Upcoming Related Reports 4

2. Executive Summary 8
2.1 KOL Insight 6
2.2 GlobalData Insight 10

3. Research Panel Composition 14
3.1 5EU 15
3.2 US 16

Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1843600

4. Results and Implications 17
4.1 Future Use of Immunotherapy 18
4.1.1 Patterns in Unmet Needs 19
4.1.2 Clinical Potential of I-O in Oncology 22
4.1.3 Optimal Place for I-O in Treatment Algorithms 24
4.2 Challenges in I-O Trial Design 26
4.2.1 Predictive Biomarkers 30
4.2.2 Clinically Relevant Endpoints 35
4.2.3 Study Recruitment 38
4.2.4 Single-Arm Studies for Regulatory Approval 40

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/